Skip to main content
Top
Published in: International Urology and Nephrology 5/2018

01-05-2018 | Nephrology - Original Paper

A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis

Authors: Chun-yan Lv, Wei-jun Ding, Yi-li Wang, Zi-yi Zhao, Jin-hui Li, Yan Chen, Jiao Lv

Published in: International Urology and Nephrology | Issue 5/2018

Login to get access

Abstract

Purpose

To assess a new and highly specific, but low-cost, easily performed and suitable for large-scale applications method for renal fibrosis (RF) diagnostics.

Methods

Thirty-five RF and twenty non-RF patients were enrolled in the study. An appropriate polyethylene glycol (PEG) was used to isolate urinary exosomes. The efficiency of isolation process was evaluated by the morphology and size observation, as well as the detection of specific markers (CD63, CD9). The expression level of exosomal miR-29c, miR-21 and the endogenous control snRNA-U6 were detected by qRT-PCR. The diagnostic potency of urinary exosomal miR-29c and miR-21 was estimated by the ROC method. Spearman’s rank-order correlations analysis was used to assess the correlation between the miRNAs and clinical parameters, including pathological index.

Results

PEG-based method for isolation urinary exosome was effective and could be completed with a relatively low-speed centrifugal machine. Exosomal miR-29c and miR-21 were detected in all samples. The analysis of miRNAs in urinary exosomes revealed significant dys-regulation of miR-29c and miR-21 associated with RF. Exosomal miR-29c and miR-21 could predict degree of RF with AUC of 0.8333 and 0.7639 (P < 0.05). Correlation analysis showed that the level of miR-29c had a significant negative relationship with eGFR and the interstitial relative area.

Conclusions

The PEG-based method for isolation urinary exosome is an inexpensive and easily performed approach. The application for cargo miRNA analysis is feasible. Urinary exosomal miR-29c may present a promising diagnostic approach.
Literature
1.
go back to reference Nogueira A, Pires MJ, Oliveira PA (2017) Pathophysiological mechanisms of renal fibrosis: a review of animal models and therapeutic strategies. In Vivo 31:1CrossRefPubMedPubMedCentral Nogueira A, Pires MJ, Oliveira PA (2017) Pathophysiological mechanisms of renal fibrosis: a review of animal models and therapeutic strategies. In Vivo 31:1CrossRefPubMedPubMedCentral
2.
go back to reference Meng XM, Nikolic-Paterson DJ, Lan HY (2014) Inflammatory processes in renal fibrosis. Nat Rev Nephrol 10:493CrossRefPubMed Meng XM, Nikolic-Paterson DJ, Lan HY (2014) Inflammatory processes in renal fibrosis. Nat Rev Nephrol 10:493CrossRefPubMed
3.
go back to reference Zanotti S, Gibertini S, Curcio M et al (2015) Opposing roles of miR-21 and miR-29 in the progression of fibrosis in Duchenne muscular dystrophy. Biochim Biophys Acta 1852:1451CrossRefPubMed Zanotti S, Gibertini S, Curcio M et al (2015) Opposing roles of miR-21 and miR-29 in the progression of fibrosis in Duchenne muscular dystrophy. Biochim Biophys Acta 1852:1451CrossRefPubMed
4.
go back to reference Roderburg C, Urban GW, Bettermann K et al (2011) Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53:209CrossRefPubMed Roderburg C, Urban GW, Bettermann K et al (2011) Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53:209CrossRefPubMed
5.
go back to reference Fang Yi, Xiaofang Yu, Liu Yong et al (2013) miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation. Am J Physiol Renal Physiol 304:F1274CrossRefPubMedPubMedCentral Fang Yi, Xiaofang Yu, Liu Yong et al (2013) miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation. Am J Physiol Renal Physiol 304:F1274CrossRefPubMedPubMedCentral
7.
go back to reference Cushing L, Kuang PP, Qian J et al (2011) miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 45:287CrossRefPubMed Cushing L, Kuang PP, Qian J et al (2011) miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 45:287CrossRefPubMed
9.
go back to reference Rubiś P, Totoń-Żurańska J, Wiśniowska-Śmiałek S et al (2017) Relations between circulating microRNAs (miR-21, miR-26, miR-29, miR-30 and miR-133a), extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy. Int J Cardiol 231:201CrossRefPubMed Rubiś P, Totoń-Żurańska J, Wiśniowska-Śmiałek S et al (2017) Relations between circulating microRNAs (miR-21, miR-26, miR-29, miR-30 and miR-133a), extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy. Int J Cardiol 231:201CrossRefPubMed
10.
go back to reference Wang G, Kwan BC-H, Lai FM-M et al (2012) Urinary miR-21, miR-29, and miR-93: novel biomarkers of fibrosis. Am J Nephrol 36:412CrossRefPubMed Wang G, Kwan BC-H, Lai FM-M et al (2012) Urinary miR-21, miR-29, and miR-93: novel biomarkers of fibrosis. Am J Nephrol 36:412CrossRefPubMed
11.
go back to reference Lv Lin-Li, Cao Yu-Han, Ni Hai-Feng et al (2013) MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis. Am J Physiol Renal Physiol 305:F1220CrossRefPubMed Lv Lin-Li, Cao Yu-Han, Ni Hai-Feng et al (2013) MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis. Am J Physiol Renal Physiol 305:F1220CrossRefPubMed
12.
go back to reference Reddy S, Hu DQ, Zhao M et al (2017) miR-21 is associated with fibrosis and right ventricular failure. JCI Insight 2:91625CrossRefPubMed Reddy S, Hu DQ, Zhao M et al (2017) miR-21 is associated with fibrosis and right ventricular failure. JCI Insight 2:91625CrossRefPubMed
14.
go back to reference Li CP, Li HJ, Nie J et al (2017) Mutation of miR-21 targets endogenous lipoprotein receptor-related protein 6 and nonalcoholic fatty liver disease. Am J Transl Res 9:715PubMedPubMedCentral Li CP, Li HJ, Nie J et al (2017) Mutation of miR-21 targets endogenous lipoprotein receptor-related protein 6 and nonalcoholic fatty liver disease. Am J Transl Res 9:715PubMedPubMedCentral
15.
go back to reference Li P, Zhao GQ, Chen TF et al (2013) Serum miR-21 and miR-155 expression in idiopathic pulmonary fibrosis. J Asthma 50:960CrossRefPubMed Li P, Zhao GQ, Chen TF et al (2013) Serum miR-21 and miR-155 expression in idiopathic pulmonary fibrosis. J Asthma 50:960CrossRefPubMed
16.
go back to reference ZununiVahed S, Omidi Y, Ardalan M et al (2017) Dysregulation of urinary miR-21 and miR-200b associated with interstitial fibrosis and tubular atrophy (IFTA) in renal transplant recipients. Clin Biochem 50:32CrossRef ZununiVahed S, Omidi Y, Ardalan M et al (2017) Dysregulation of urinary miR-21 and miR-200b associated with interstitial fibrosis and tubular atrophy (IFTA) in renal transplant recipients. Clin Biochem 50:32CrossRef
18.
go back to reference Weng Y, Sui Z, Shan Y et al (2016) Effective isolation of exosomes with polyethylene glycol from cell culture supernatant for in-depth proteome profiling. Analyst 141:4640CrossRefPubMed Weng Y, Sui Z, Shan Y et al (2016) Effective isolation of exosomes with polyethylene glycol from cell culture supernatant for in-depth proteome profiling. Analyst 141:4640CrossRefPubMed
19.
go back to reference Radford MG, Donadio JV, Bergstral HE et al (1997) Predicting renal outcome in IgA nephropathy. Jan SocNephrol 8:199 Radford MG, Donadio JV, Bergstral HE et al (1997) Predicting renal outcome in IgA nephropathy. Jan SocNephrol 8:199
20.
go back to reference Mizuguchi Y, Miyajima A, Kosaka T et al (2004) Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction. Urol 172:2456CrossRef Mizuguchi Y, Miyajima A, Kosaka T et al (2004) Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction. Urol 172:2456CrossRef
21.
go back to reference Kretzler M (2005) Role of podocytes in focal sclerosis: defining the point of no return. J Am Soc Nephrol 16:2830CrossRefPubMed Kretzler M (2005) Role of podocytes in focal sclerosis: defining the point of no return. J Am Soc Nephrol 16:2830CrossRefPubMed
22.
go back to reference Raij L, Azars S, Keane W (1984) Mesangial immune injury, hypertension, and progressive glomerular damage in dahl rats. Kidney Int 43:137CrossRef Raij L, Azars S, Keane W (1984) Mesangial immune injury, hypertension, and progressive glomerular damage in dahl rats. Kidney Int 43:137CrossRef
23.
go back to reference Miranda KC, Bond DT, McKee M et al (2010) Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int 78:191CrossRefPubMedPubMedCentral Miranda KC, Bond DT, McKee M et al (2010) Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int 78:191CrossRefPubMedPubMedCentral
24.
go back to reference Erdbrügger U, Le TH (2015) Extracellular vesicles in renal diseases: more than novel biomarkers? J Am SocNephrol 27:12 Erdbrügger U, Le TH (2015) Extracellular vesicles in renal diseases: more than novel biomarkers? J Am SocNephrol 27:12
25.
go back to reference Franzen CA, Blackwell RH, Foreman KE et al (2016) Urinary exosomes: the potential for biomarker utility, intercellular signaling and therapeutics in urological malignancy. J Urol 195:1331CrossRefPubMed Franzen CA, Blackwell RH, Foreman KE et al (2016) Urinary exosomes: the potential for biomarker utility, intercellular signaling and therapeutics in urological malignancy. J Urol 195:1331CrossRefPubMed
26.
go back to reference Dear JW, Street JM, Bailey MA (2013) Urinary exosomes: a reservoir for biomarker discovery and potential mediators of intrarenal signalling. Proteomics 13:1572CrossRefPubMed Dear JW, Street JM, Bailey MA (2013) Urinary exosomes: a reservoir for biomarker discovery and potential mediators of intrarenal signalling. Proteomics 13:1572CrossRefPubMed
27.
go back to reference Beringer PM, Hidayat L, Heed A et al (2009) GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis. J Cyst Fibros 8:19CrossRefPubMed Beringer PM, Hidayat L, Heed A et al (2009) GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis. J Cyst Fibros 8:19CrossRefPubMed
29.
go back to reference Jeppesen DK, Hvam ML, Primdahl-Bengtson B et al (2014) Comparative analysis of discrete exosome fractions obtained by differential centrifugation. J Extracell Vesicles 3:25011CrossRefPubMed Jeppesen DK, Hvam ML, Primdahl-Bengtson B et al (2014) Comparative analysis of discrete exosome fractions obtained by differential centrifugation. J Extracell Vesicles 3:25011CrossRefPubMed
30.
go back to reference Tauro BJ, Greening DW, Mathias RA et al (2013) Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Mol Cell Proteomics 12(3):587–598CrossRefPubMed Tauro BJ, Greening DW, Mathias RA et al (2013) Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Mol Cell Proteomics 12(3):587–598CrossRefPubMed
Metadata
Title
A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis
Authors
Chun-yan Lv
Wei-jun Ding
Yi-li Wang
Zi-yi Zhao
Jin-hui Li
Yan Chen
Jiao Lv
Publication date
01-05-2018
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 5/2018
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1779-4

Other articles of this Issue 5/2018

International Urology and Nephrology 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.